ERGOSTAT Drug Patent Profile
Which patents cover Ergostat, and what generic alternatives are available?
Ergostat is a drug marketed by Watson Labs Inc and is included in one NDA.
The generic ingredient in ERGOSTAT is ergotamine tartrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ERGOSTAT?
- What are the global sales for ERGOSTAT?
- What is Average Wholesale Price for ERGOSTAT?
Summary for ERGOSTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Clinical Trials: | 1 |
| Patent Applications: | 53 |
| DailyMed Link: | ERGOSTAT at DailyMed |
Recent Clinical Trials for ERGOSTAT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stanford University | Phase 2 |
US Patents and Regulatory Information for ERGOSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Inc | ERGOSTAT | ergotamine tartrate | TABLET;SUBLINGUAL | 088337-001 | Jun 8, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
